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MaOBJECTIVES The aim of this study was to verify the hypothesis that multidetector computed tomography
(MDCT) is superior to echocardiography for measuring the left ventricular outﬂow tract (LVOT) and calculating
the aortic valve area (AVA) with regard to hemodynamic correlations and survival outcome prediction after
a diagnosis of aortic stenosis (AS).
BACKGROUND MDCT demonstrated that the LVOT is noncircular, casting doubt on the AVA measurement by
2-dimensional (2D) echocardiography.
METHODS A total of 269 patients (76  11 years of age, 61% men) with isolated calciﬁc AS (mean gradient
44  18 mm Hg; ejection fraction 58  15%) underwent Doppler echocardiography and MDCT within the same
episode of care. AVA was calculated by echocardiography (AVAEcho) and by MDCT (AVACT) using each technique
measurement of LVOT area. In the subset of patients undergoing dynamic 4-dimensional MDCT (n ¼ 135),
AVA was calculated with the LVOT measured at 70% and 20% of the R-R interval and measured by planimetry
(AVAPlani).
RESULTS Phasic measurements of the LVOT by MDCT yielded slight differences in eccentricity and size (all
p < 0.001) but with excellent AVA correlation (r ¼ 0.92, p < 0.0001) and minimal bias (0.05 cm2), whereas the
AVAPlani showed poor correlations with all other methods (all r values <0.58). AVACT was larger than AVAEcho
(difference 0.12  0.16 cm2; p < 0.0001) but did not improve outcome prediction. Correlation gradient-AVA was
slightly better with AVAEcho than AVACT (r ¼ 0.65 with AVAEcho vs. 0.61 with AVACT; p ¼ 0.01), and discordant
gradient-AVA was not reduced. For long-term survival, after multivariable adjustment, AVAEcho or AVACT were
independently predictive (hazard ratio [HR]: 1.26, 95% conﬁdence interval [CI]: 1.13 to 1.42; p < 0.0001 or HR:
1.18, 95% CI: 1.09 to 1.29 per 0.10 cm2 decrease; p < 0.0001) with a similar prognostic value (p $ 0.80).
Thresholds for excess mortality differed between methods: AVAEcho #1.0 cm
2 (HR: 4.67, 95% CI: 2.22 to 10.50;
p < 0.0001) versus AVACT #1.2 cm2 (HR: 3.16, 95% CI: 1.64 to 6.43; p ¼ 0.005), with simple translation of
spline-curve analysis.
CONCLUSIONS Head-to-head comparison of MDCT and Doppler echocardiography refutes the hypothesis of MDCT
superiority for AVA calculation. AVACT is larger than AVAEcho but does not improve the correlation with transvalvular
gradient, the concordance gradient-AVA, or mortality prediction compared with AVAEcho. Larger cut-point values should
be used for severe AS if AVACT (<1.2 cm
2) is measured versus AVAEcho (<1.0 cm
2). (J Am Coll Cardiol Img 2015;8:248–57)
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AB BR EV I A T I O N S
AND ACRONYM S
AS = aortic stenosis
AVA = aortic valve area
AVAEcho = aortic valve area
measured by Doppler
echocardiography
AVACT = aortic valve area
measured by computed
tomography
AVR = aortic valve
replacement
DP = mean gradient
HR = hazard ratio
LVOT = left ventricular
outﬂow tract
MDCT = multidetector
computed tomography
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249A ortic stenosis (AS) is a frequent valvular dis-ease (1) treatable only by valve replacement,surgical or percutaneous (transcatheter aortic
valve replacement [TAVR]) (2,3). Because TAVR does
not allow intraprocedural valve sizing, evaluation of
the ventriculoaortic transition zone has become an
essential goal of aortic valvular imaging to avoid
complications of TAVR such as prosthesis emboliza-
tion, aortic annulus rupture, and paravalvular leak
(4–6). This new requirement of thorough pre-
procedural aortic apparatus evaluation has led to
3-dimensional (3D) imaging studies using 3D echo-
cardiography (7) or multidetector computed tomog-
raphy (MDCT) (8), which suggested that the “aortic
annulus” was complex, often noncircular (9,10) and
concluded that MDCT provided superior annular
measurement compared with standard 2D echocardi-
ography (11,12).SEE PAGE 258
TAVR = transcatheter aortic
valve replacementHowever, “aortic annulus” measurements, if
improper, would have wide-ranging implications
regarding AS hemodynamic assessment. Noninvasive
aortic valve area (AVA) calculation requires aortic
annular (or left ventricular outﬂow tract [LVOT])
cross-sectional area (LVOTArea) (13), which for
Doppler echocardiography uses a disputed single-
diameter measurement. AVA measured by Doppler
echocardiography (AVAEcho) has long been regarded
as validated and as part of routine clinical practice
but recently has been criticized as underestimating
AVA calculated with the more anatomically sound
LVOTArea measured by MDCT (AVACT) (7,11,12).
The possibility that a faulty AVAEcho may bear re-
sponsibility for “discordant” AS cases, with low
gradient despite tight AVA, resonates with other
challenges to the authenticity of this syndrome (14).
The contrast between AVAEcho being revered as fully
validated and as the major independent predictor of
outcome in AS and being reviled as anatomically
illogical and underestimated versus AVA measured
by computed tomography (AVACT) has not been
resolved and is crucial to the management of pa-
tients with AS.
Thus, the aims of our study were as follows: 1) to
verify whether the discordant hemodynamic pattern
in AS is associated with aortic “annulus” asymmetry
and resolved by use of AVACT versus AVAEcho; 2) to
assess whether the association between gradient and
AVA is improved by the use of AVACT versus AVAEcho;
and 3) to assess whether the association between AVA
and survival after a diagnosis of AS is improved by
use of AVACT versus AVAEcho. Our main hypothesis is
that AVACT will be superior to AVAEcho with regardto discordant AS severity grading, hemody-
namic correlations, and clinical outcome
impact. However, our secondary hypothesis
is that thresholds to deﬁne severe AS will be
higher by AVACT than by AVAEcho.
METHODS
We analyzed data for 269 adult AS patients
who underwent comprehensive Doppler
echocardiography and contrast-enhanced
MDCT within the same episode of care (<3
months between evaluations). We excluded
children younger than 18 years of age, pa-
tients with identiﬁed rheumatic disease or
endocarditis, and those with moderate or
severe mitral valve disease and/or previous
valve repair or replacement.
Patients were enrolled in a prospective
clinical research study initiated by the
Valvular Heart Disease Clinic. Informed consent was
obtained according to institutional review board
approval. The CT angiography (with contrast) was
performed to address clinical questions: 1) uncer-
tainty regarding AS severity; 2) questions regarding
LVOT in known AS; 3) in known AS, vascular in-
dications regarding the status of the aorta or periph-
eral vessels; and 4) questions regarding the presence
or severity of coronary artery disease.
DOPPLER ECHOCARDIOGRAPHY MEASUREMENTS.
Left ventricular dimensions, peak aortic jet velocity,
mean gradient (DP), and left ventricular ejection
fraction were measured according to recommenda-
tions of the American Society of Echocardiography
(13). Doppler echocardiographic LVOT diameter was
measured at the base of the valve leaﬂets (Figure 1)
and used to calculate LVOTArea using echocardiog-
raphy:
LVOTAreaEcho ¼ p

LVOTdiameter
2
2
AVAEcho was then calculated by the continuity equation:
AVAEcho ¼ LVOTAreaEcho 
VTILVOT
VTIAo
where VTILVOT and VTIAo are the velocity time in-
tegrals of the LVOT and transaortic ﬂow, respectively.
MDCT IMAGING AND MEASUREMENTS. The contrast-
enhanced electrocardiography-gated MDCT exami-
nations were performed with a 64-detector scanner
(Sensation 64, Siemens Medical Systems, Forchheim,
Germany), without the routine use of b-blocker
medications (Online Appendix). Dynamic LVOT
assessment was performed in patients in whom the
FIGURE 2 Method
(A, B) Two orthogon
and measurements.
FIGURE 1 Method for Measurement of LVOT Dimensions by
Echocardiography
From a zoomed parasternal long-axis view, the left ventricular
outﬂow tract (LVOT) diameter is measured during systole. The
blue line is drawn from the insertion of the aortic cusp at the
level of ventricular septum to the insertion of the aortic cusp at
the level of the anterior mitral leaﬂet.
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and LVOT was recorded and available for quantitative
analysis during all phases of the cardiac cycle (n ¼
135). Dynamic LVOT measurement involved tracingfor Measurement of LVOT Dimensions by Computed Tomography
al plans used to deﬁne LVOT plan. (C) LVOT plan. (D) Zoomed LVOT
LVOT ¼ left ventricular outﬂow tract.the LVOT contour at 70% and 20% of the R-R interval,
allowing the calculation of AVACT in diastole
(AVACT-D) and AVACT in systole (AVACT-S), respec-
tively. Cardiac MDCT was performed using between
80 and 105 ml of isomolar contrast medium.
All LVOT imaging was performed using the same
process with dedicated software (Aquarius iNtuition,
TeraRecon, Inc., Foster City, California), involving
orientation of a cross-sectional plane of LVOT by us-
ing 3 orthogonal planes from multiplanar recon-
struction (Figures 2A to 2C) and located at or
immediately under the lowest implantation base of
aortic cusps (Figure 2C). Once this plane was secured,
the LVOT contour was traced, 2 orthogonal diameters
were directly measured, and the area of LVOT (LVO-
TAreaCT) was planimetered (Figure 2D). The eccen-
tricity index of the aortic valve annulus was
calculated by dividing the smaller diameter by the
larger one.
AVACT was calculated by using the measured
LVOTAreaCT in the continuity equation:
AVACT ¼ LVOTAreaCT  VTILVOTVTIAo
In patients with dynamic imaging and full 4-
dimensional MDCT volumes, the imaging plane was
translated to the tips of the aortic cusps in systole,
and planimetry of the aortic valve opening (AVAPlani)
was measured.
STUDY ENDPOINT. To assess the respective value of
AVA measurements obtained by Doppler echocardi-
ography and MDCT, we examined several endpoints,
including the relationship between DP and AVAs and
the prevalence of discordant AS severity grading. The
primary endpoint of this study was the overall sur-
vival under medical treatment. Hence, the end of
follow-up was marked by aortic valve replacement
(AVR) for patients operated on or by death or last
known follow-up for patients not operated on. Patients
were thus censored (follow-up stopped) at AVR. The
secondary endpoint was total mortality during the
entire follow-up (i.e., medical and post-AVR) (Online
Table 1). Therapeutic decisions in our study were made
by the patients’ personal physicians based on all the
information available. The decision to not operate
immediately after the ﬁrst evaluation was in this cohort
mostly linked to nonsevere AS but also to asymptomatic
AS or to symptoms interpreted as unrelated to AS. Only
10% of our patients were considered potentially high
operative risk.
Outcome data were obtained from the annual visit
of the patient or the patient’s charts, mailed ques-
tionnaires or scripted telephone interviews with
the patients or physicians, and death certiﬁcates.
TABLE 1 Baseline Characteristics of the Population
Whole
Cohort
(N ¼ 269)
LVOT
Eccentricity <0.8
(n ¼ 134)
LVOT
Eccentricity $0.8
(n ¼ 135) p Value
Clinical data
Age, yrs 76  11 77  11 75  9 0.09
Male 163 (61) 80 (60) 83 (61) 0.77
Body mass index, kg/m2 28.9  6.8 28.3  0.5 29.4  7.2 0.17
Body surface area, m2 1.91  0.25 1.89  0.26 1.92  0.23 0.25
Diastolic blood pressure, mm Hg 69  11 70  11 69  11 0.79
Systolic blood pressure, mm Hg 127  18 126  18 128  18 0.35
Heart rate, beats/min 69  13 70  13 68  13 0.49
NYHA functional class $III 122 (45) 68 (51) 54 (40) 0.08
Diabetes 77 (29) 35 (26) 42 (31) 0.39
Hypertension 185 (69) 92 (69) 93 (69) 0.97
Coronary artery disease 131 (49) 67 (50) 64 (47) 0.67
Chronic pulmonary disease 69 (26) 37 (28) 32 (23) 0.31
Echocardiographic data
LVOT diameter, mm 2.21  0.20 2.20  0.20 2.22  0.20 0.42
LVOT area, cm2 3.86  0.71 3.82  0.71 3.89  0.72 0.42
LV end-diastolic diameter, cm 4.96  0.73 5.02  0.78 4.90  0.66 0.20
LV end-systolic diameter, cm 3.31  0.89 3.42  0.94 3.20  0.83 0.06
Stroke volume (LVOT), ml 87  21 87  22 90  19 0.21
Peak aortic jet velocity, m/s 4.2  0.9 4.3  0.9 4.1  0.8 0.03
Mean gradient, mm Hg 44  18 47  20 41  15 0.009
AVA, cm2 0.94  0.32 0.90  0.31 0.98  0.33 0.05
AVAi, cm2/m2 0.50  0.17 0.48  0.16 0.51  0.17 0.14
LV ejection fraction, % 58  15 55  15 60  12 0.002
AVA #1 cm2 and mean
gradient <40 mm Hg
66 (25) 34 (25) 32 (24) 0.75
Static MDCT data
Large LVOT diameter, cm 2.76  0.34 2.91  0.31 2.61  0.29 <0.0001
Small LVOT diameter, cm 2.17  0.23 2.12  0.22 2.22  0.23 0.0001
LVOT eccentricity index 0.79  0.08 0.73  0.04 0.85  0.05 <0.0001
LVOT area, cm2 4.68  1.02 4.80  1.06 4.55  0.97 0.04
Stroke volume, ml 108  29 109  31 106  26 0.27
AVA, cm2 1.13  0.44 1.12  0.44 1.15  0.45 0.67
AVAi, cm2/m2 0.60  0.23 0.60  0.23 0.60  0.23 0.98
Values are mean  SD or n (%).
AVA ¼ aortic valve area; AVAi ¼ indexed aortic valve area; LV ¼ left ventricular; LVOT ¼ left ventricular
outﬂow tract; MDCT ¼ multidetector computed tomography; NYHA ¼ New York Heart Association.
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251We obtained complete follow-up up to AVR, to death,
or to the year preceding freezing of the dataset in 96%
of patients (258 of 269), and the 11 patients with
incomplete follow-up contributed to outcome infor-
mation for the duration of known follow-up.
STATISTICAL ANALYSIS. Results are expressed as
mean  SD or percentage. Differences between the 4
methods of AVA measurements were analyzed using
1-way repeated-measures analysis of variance fol-
lowed by the Tukey test. Correlation and agreement
between the different LVOTs and AVAs were deter-
mined with the use of the Pearson correlation and
Bland-Altman methods, respectively. Relationships
between AVAs and DP were assessed with multiple
regression models, and the equation providing the
best ﬁt was retained. Comparison between correlation
coefﬁcients used the Wolfe test. The comparison of
patient’s classiﬁcation between AVAEcho and AVACT
was done with the McNemar test.
To analyze the effect of AVAEcho and AVACT on
mortality, we used spline curve graphs where the
x-axis represents AVA and the y-axis the relative risk
of mortality. The effect of the clinical, Doppler echo-
cardiographic, and MDCT variables on survival under
medical treatment was assessed using Cox propor-
tional hazard models adjusted for age-adjusted
Charlson score index (15), sex, symptoms, DP, and
left ventricular ejection fraction. Analysis of overall
mortality during the entire follow-up was done with
adjustment for age, sex, symptoms, coronary artery
disease, chronic obstructive pulmonary disease, dia-
betes, hypertension, DP, left ventricular ejection
fraction, and AVR as a time-dependent variable. All
variables in the Cox models veriﬁed the proportional
hazards assumption on the basis of inspection of
trends in the Schoenfeld residuals (all p > 0.32). The
results of the Cox proportional hazards were pre-
sented with hazard ratio and 95% conﬁdence interval.
The accuracy of the Cox model was assessed by the
Harrell C index and compared by bootstrapping. A
p value <0.05 was considered statistically signiﬁcant.
RESULTS
BASELINE CHARACTERISTICS. Overall, at baseline,
patient age was 76  11 years, and 163 patients (61%)
were male (Table 1). In terms of comorbidity, preva-
lence of hypertension (79%), diabetes (29%), coronary
artery disease (49%), and chronic pulmonary disease
(26%) were as expected in a population of that age.
Doppler characteristics were DP 44  18 mm Hg and
peak velocity 4.2  0.9 m/s.
Evaluation by static MDCT showed that LVOTArea
was generally elliptical (93% patients had more than10% difference between LVOT diameters), with an
eccentricity index of 0.79  0.08 in the entire cohort
(Table 1). Categorized in the entire cohort using the
median LVOT static eccentricity index (i.e., 0.8), pa-
tients with the most elliptical annulus (eccentricity
index <0.8) had few differences (Table 1) with slightly
more severe AS with higher peak velocity (p ¼ 0.03)
and DP (p ¼ 0.009) and smaller AVA calculated by
Doppler echocardiography, and reduced ejection
fraction (p ¼ 0.002) compared with patients with
more circular annulus.
ECHOCARDIOGRAPHIC AND DYNAMIC MDCT MEASURE-
MENTS OF AVA. As LVOTArea (Online Appendix), AVA
was different in all methods, with echocardiography
measuring the smallest values and with considerable
FIGURE 3 4 Methods of AVA Measurement in Patients
With 4-Dimensional MDCT Available According to
Echocardiographic AVA
pmethods < 0.001
pinteraction = 0.07
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Echocardiographic AVA # 1 cm2 are reported in pink and AVA
>1 cm2 in green. Note the similar distribution of aortic valve area
with MDCT in systole and diastole, whereas direct aortic valve
planimetry in systole is associated with marked widening of
distribution. AVA ¼ aortic valve area; CT ¼ computed tomogra-
phy; Echo ¼ echocardiography; MDCT ¼multidetector computed
tomography.
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252dispersion of values for AVAPlani compared with other
methods (Figure 3). The correlations between AVAEcho
and either AVACT-D or AVACT-S (at 70% and 20% of
R-R, respectively) were good and equivalent (both
r values ¼ 0.78, p < 0.0001) (Online Figure 1) with
modest dispersion. The correlations obtained with
AVAPlani and any other method were signiﬁcant but
much poorer (all r values <0.58) (Online Figure 1).
Conversely, the correlation between phasic calcula-
tions of AVA by MDCT was excellent (r ¼ 0.92,FIGURE 4 Correlations Between Mean Gradient and AVA in the Who
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The AVA was calculated by Doppler echocardiography (AVAEcho) (A) or
ventricular outﬂow tract measurement (AVACT) (B). AVA ¼ aortic valvep < 0.0001), with signiﬁcant but minimal differences
(mean 0.05 cm2) (Online Figures 1E and 1F). In view of
these excellent dynamic-static LVOT/AVA measure-
ment correlations, static measurements were used in
the entire population with regard to grading consis-
tency and survival. Accordingly, in the whole cohort,
the correlation between AVAEcho and AVACT was good
and with modest dispersion (Online Figure 2).
RELATIONSHIP BETWEEN DP AND AVACT OR
AVAECHO. First, regression between DP and AVA,
AVAEcho, or AVACT was analyzed. The correlation
between DP and AVA was better (Wolfe test, p ¼ 0.01)
for AVAEcho (r ¼ 0.65, p < 0.0001) than static AVACT
(r ¼ 0.61, p < 0.0001) (Figure 4). The use of indexed
AVA provided the same results (see the Online
Appendix, Online Figure 3). Thus, AVACT compared
with AVAEcho, despite its accounting for LVOT ec-
centricity, does not improve hemodynamic correla-
tion of AVA-DP. When stratiﬁed by eccentricity index,
the correlation AVA-DP tended to be weaker
in patients with a more oval LVOT (i.e., eccentricity
index <0.8), irrespective of the method used to
measure AVA, but regression slopes were not
affected, and use of MDCT to assess AVA did not
improve AVA-gradient correlations and regressions in
any subset (Figure 5). For purposes of completeness,
we veriﬁed that dynamic MDCT (AVACT-S) did not
improve the AVA-gradient relationship (all p values
>0.25) over static MDCT, whereas measuring AVA by
planimetry worsened the AVA-gradient correlations
(all comparisons, p # 0.04).
Second, the usefulness of AVACT to resolve
discordant AS severity grading was analyzed. Of
our 269 patients, 66 (25%) had a low gradient
(<40 mm Hg) despite a tight AVAEcho. This prevalencele Cohort
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FIGURE 5 Correlations Between Mean Gradient and AVA According to LVOT Eccentricity
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AVAEcho (A) and AVACT (B) in the whole cohort. p is the p value of the correlation between the mean gradient and AVA. pi is the p value of the
interaction of AVA and LVOT eccentricity with regard to mean gradient. Abbreviations as in Figures 2 and 4.
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253was not different among patients with a high or
low LVOT eccentricity index (p ¼ 0.75) (Table 1).
Patients classiﬁed as concordant AS assessment
(either AVA #1.0 cm2 combined with DP $40 mm Hg
or AVA more than 1.0 cm2 with DP <40 mm Hg) rep-
resented 74% by AVAEcho and 70% by AVACT
(p ¼ 0.15), showing that AVACT did not improve the
concordance of AS severity grading.
Using speciﬁc thresholds for each method did
not show improvement of grading by AVACT (Online
Appendix).
IMPACT OF AVAECHO AND AVACT ON SURVIVAL IN AS.
During a mean follow-up of 2.0  1.4 years under
medical treatment, there were 55 deaths (Online
Table 1). On univariable and multivariable analyses,
AVA calculated by echocardiography (p < 0.0001) or
by MDCT (p < 0.0001) were independent predictors of
mortality under medical treatment (Table 2). How-
ever, the negative impact on survival under medical
treatment occurred for different thresholds for
AVAEcho and AVACT, as shown by the spline curves
linking relative risk mortality under medical man-
agement and the 2 AVA types as continuous variables
(Figure 6, Online Appendix). As dichotomized vari-
ables, AVAEcho #1.0 cm2 (p < 0.0001) and AVACT #1.2
cm2 (p ¼ 0.005) were independent predictors of
mortality under medical treatment (Table 2, Figure 7).
Importantly, as continuous or dichotomized vari-
ables, AVAEcho and AVACT showed equivalent power
to predict mortality under medical treatment using
Harrell C index and net reclassiﬁcation index (Table 2,
Online Appendix).Interestingly, AVAEcho #0.8 cm2 and AVACT #1.0
cm2 were not independent predictors of mortality
(Table 2, Figure 7).
These results were conﬁrmed in the entire follow-
up (3.2  2.5 years) (Online Table 1), with further
adjustment for AVR as a time-dependent variable.
AVAEcho and AVACT were independent predictors
of total mortality as continuous variables (all p
values ¼ 0.02) as well as dichotomized variables
(all p values #0.03).
DISCUSSION
Our study compares for the ﬁrst time AVA by using
Doppler echocardiography and MDCT obtained dur-
ing the same episode of care in the same patients with
AS with regard to hemodynamic correlations, discor-
dance in AS severity grading, and clinical outcome
impact. We ﬁrst conﬁrm that using static or dynamic
MDCT for AVA calculation is equivalent with a mini-
mum bias between phasic measurements. However,
the measurement of AVA by planimetry should be
avoided given that this measure provides the lowest
correlation with the other methods and worsens the
association AVA-gradient. Although the larger AVA by
planimetry may not be surprising as it measures
anatomic (vs. effective) oriﬁce area, the dispersion of
values and poor correlations with gradient reﬂect
inconsistent measurements. The most important
result of our study addresses the hypothesis that
AVACT is superior to AVAEcho, which is not veriﬁed by
any of the measured endpoints. Indeed, although
AVACT is larger than AVAEcho, the AVA-gradient
TABLE 2 Univariable and Multivariable Analysis of Impact of AVA Calculated by Echocardiography or Computed Tomography on Mortality
Under Medical Treatment in the Whole Cohort
Increment
AVAEcho AVACT p Value for
Harrell C Index
ComparisonHR (95%CI) p Value
Harrell
C Index HR (95% CI) p Value
Harrell
C Index
Univariable 0.10 cm2 1.33 (1.20–1.49) <0.0001 0.824 1.23 (1.14–1.33) <0.0001 0.825 0.98
Multivariable 1.26 (1.13–1.42) <0.0001 0.802 1.18 (1.09–1.29) <0.0001 0.799 0.96
Univariable Speciﬁc threshold 6.90 (3.53–14.64) <0.0001 0.842 5.32 (2.88–10.52) <0.0001 0.845 0.94
Multivariable (1.0 and 1.2 cm2)* 4.67 (2.22–10.50) <0.0001 0.793 3.16 (1.64–6.43) 0.005 0.803 0.93
Univariable Speciﬁc threshold 3.79 (2.20–6.58) <0.0001 0.774 3.17 (1.82–5.56) <0.0001 0.782 0.81
Multivariable (0.8 and 1.0 cm2)† 1.28 (0.78–2.45) 0.31 — 1.43 (0.77–2.64) 0.25 — —
Multivariable analyses are adjusted for age-adjusted Charlson score index, sex, symptoms, mean gradient, and left ventricular ejection fraction. *AVAEcho #1.0 cm2 and
AVACT #1.2 cm
2. †AVAEcho #0.8 cm
2 and AVACT #1.0 cm
2.
AVA ¼ aortic valve area; AVACT ¼ aortic valve area calculated by computed tomography; AVAEcho ¼ aortic valve area calculated by echocardiography; HR ¼ hazard ratio;
CI ¼ conﬁdence interval.
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254relationship is not improved, and the frequency of
discordant AS grading is unaffected, showing that, as
a rule, the use of MDCT results in a translation of the
correlation curves. Although our study shows for the
ﬁrst time that AVACT independently determines sub-
sequent survival, this method did not improve
outcome prediction compared with AVAEcho. Howev-
er, thresholds affecting mortality were different for
AVACT and AVAEcho, with spline curves demon-
strating a simple translation of mortality prediction to
higher values for AVACT.
THE COMPLEX ANATOMY OF THE VENTRICULOAORTIC
COMPLEX. The aortic valve has a complex structure
(16). Until recently, little attention has been paid to
this anatomic complexity, but recent work showed
that the LVOTArea imaged by 3D imaging techniques
does not have the previously presumed circular
shape (9,10), and our data conﬁrms a generally
elliptical shape of the LVOT. The previous rule by 2D
Doppler echocardiography, using the parasternalFIGURE 6 Spline Curves of Relative Risk of Mortality According to t
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The curves show the impact of aortic valve area measured by Doppler ec
under medical treatment in the whole cohort. Dashed lines are 95% colong-axis view, was to measure the diameter, alter-
natively called aortic annulus and LVOT, at the level
of presumed lowest implantation of leaﬂets (17). 3D
imaging techniques directly measuring of the entire
area of the LVOT/annulus with orthogonal posi-
tioning ascertained by locating the bottom of all
aortic cusps suggested that 2D Doppler echocardiog-
raphy underestimated (8,11,12,18) this measurement.
This issue of smaller LVOTArea calculated by 2D than
measured by MDCT, which we undeniably conﬁrm,
has been labeled as “underestimation of the LVOT
area” and has led to calls for the replacement of 2D
annular measurement by 3D measurements in the
calculation of the AVA (11,12,18). Such appeals are
troubling because 2D measurements of AVA have
been widely validated (17,19,20). Hence, it is essential
to examine from physiological and outcome points of
view whether Doppler echocardiography calculation
of the AVA is superseded by the “superior” MDCT
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FIGURE 7 Kaplan-Meier Curves of Survival Under Medical Treatment
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Kaplan-Meier curves are presented according to AVAEcho #1.0 cm
2 (A), AVACT #1.2 cm2 (B), AVAEcho #0.8 cm2 (C), and AVACT #1.0 cm2 (D) in
the whole cohort. Note: Follow-up was complete, up to aortic valve replacement, death, or the year preceding freezing of the dataset in 96%
of patients (258 of 269), and the 11 patients with incomplete follow-up contributed outcome information for the duration of known follow-up.
Abbreviations as in Figure 4.
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255PHYSIOLOGICAL COMPARISONS OF MDCT VERSUS
DOPPLER ECHOCARDIOGRAPHY MEASUREMENTS.
MDCT and Doppler echocardiography measurements
of LVOTArea provide different AVAs so that AVAEcho
is generally 0.1 to 0.2 cm2 smaller than AVACT
(7,11,12). This different AVA calculation obtained by
different methods increases the confusion regarding
the best threshold of AVA identifying severe AS.
Indeed, there is a purported inconsistency between
echocardiographic criteria for grading AS, whereby an
AVA of 1 cm2 is touted as corresponding to a DP of 30
mm Hg, whereas a DP of 40 mm Hg would instead
correspond to an AVA of 0.8 cm2 (21). Hence,
although guidelines indicate 1.0 cm2 as the threshold
for severe AS (2,22), it has been proposed (21) that this
threshold for AVAEcho should be decreased to 0.8 cm2.
This drastic change would conﬂict with outcome
studies showing excess mortality (23) in AS with an
AVA #1.0 cm2, whereas no study has shown a supe-
riority of AVA #0.8 cm2 in predicting mortality. In
that regard, our study provides important informa-
tion. First, it shows that AVACT, despite accounting
for the LVOT elliptical shape, provides no superiorprediction of survival compared with AVAEcho. Sec-
ond, our spline analysis shows that the threshold of
excess mortality is indeed an AVA #1.0 cm2 for
AVAEcho, whereas it is an AVA #1.2 cm2 for AVACT
with spline curves showing a simple translation be-
tween these 2 methods. Third, AVAEcho #0.8 cm2 and
AVACT #1.0 cm2 are not independent predictors of
mortality. Thus, despite the elliptical shape of the
LVOT (9,10), discrepancies between MDCT measure-
ments and direct annular sizing (24) suggest that
MDCT and 2D echocardiography do not measure
exactly the same structure. An alternate explanation
of echocardiography–computed tomography discrep-
ancies may reside with ﬂuid dynamics, as blood ve-
locity is null at the wall level, so that the effective
ﬂow area may be more circular than the anatomic
elliptical LVOTArea, potentially leading to over-
estimation of the ﬂow surface and stroke volume by
computed tomography. Furthermore, stroke volume
and AVA measured by Doppler echocardiography has
been validated in studies comparing AVAEcho and
AVA calculated by catheterization (19,20,25) or mag-
netic resonance (26).
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256Hence, with the hypothesis that MDCT provides
superior measurement not veriﬁed, measuring LVOT
Area by MDCT is not required in clinical routine, un-
less poor imaging windows preclude aortic annular
measurement or TAVR is planned. Indeed, measure-
ment of the mean LVOT diameter and perimeter by
MDCT has been linked to better sizing of trans-
catheter prostheses and to lower post-procedural
paravalvular regurgitation (27,28).
STUDY LIMITATIONS. For image stability, static ac-
quisitions were done in the whole cohort at 70%
of the R-R interval, and a large number of patients
had only static acquisition for minimizing radiation
exposure. In patients with dynamic MDCT, we were
able to assess phasic variations of LVOTArea. The
impact of phasic variations on AVA calculation is
signiﬁcant but minimal. The fact that these phasic
changes did not inﬂuence the regression between
the AVA and DP is reassuring. There is no clinically
available method yet to coregister images from 2D
echocardiography and MDCT to prove beyond a doubt
that measurements provided by these 2 techniques
are not of the exact same anatomic structure, but
imaging progress will soon allow such overlay and
allow veriﬁcation of this hypothesis. For now, our
data showing the equivalent hemodynamic and
outcome value of these techniques suggest that the
history accumulated with Doppler echocardiography
should not be discarded and that guidelines need not
be revised for the management and severity assess-
ment of AS. The combined endpoint of AVR or death
was not used in the study due to potential bias
(AVAEcho guided decision making for AVR) and the
lack of increased power with this frequent event
(Online Table 1). This study should be conﬁrmed by
larger studies with longer follow-up.
CONCLUSIONS
This study showed that the hypothesis that AVA
calculated using LVOTArea measured by MDCT is
superior to AVA assessed by Doppler echocardiogra-
phy is not veriﬁed with regard to hemodynamic cor-
relations, to discordant AS severity grading, and toclinical outcome impact. Indeed, although AVACT is
larger than AVAEcho, the AVA-gradient relationship is
not improved and the use of MDCT results in a simple
translation of mortality spline curves. Furthermore,
our study shows that AVAEcho is an independent
predictor of survival under medical treatment with a
threshold affecting mortality of AVAEcho #1.0 cm2.
Thus, LVOT measurement by MDCT should not
replace Doppler echocardiography for hemodynamic
assessment of AS severity. Despite suggestions to
the contrary, our study ﬁnds no rationale in
altering current guidelines in terms of use of Doppler
echocardiography and threshold-guiding AS man-
agement, but conversely suggests that MDCT may be
useful in patients with poor annular imaging by
echocardiography.
CLINICAL IMPLICATIONS. Doppler echocardiography
is the ﬁrst-line examination for evaluation of AS
severity. Asymmetrical LVOT by 3D imaging raised
concerns about 2D echocardiographic AVA calcula-
tion accuracy but AVA calculation by MDCT does not
improve grading concordance or outcome predic-
tion. There are differences between echocardiogra-
phy and computed tomography measurements, but
echocardiography-measured AVA is not inferior
to that calculated using LVOT by MDCT. Moreover,
based on survival after diagnosis, thresholds de-
ﬁning severe AS should be different: 1.2 cm2 for AVA
by MDCT instead of 1.0 cm2 for AVA by 2D echo-
cardiography. Thus, measurement of LVOT diameter
by MDCT is a valuable method to calculate AVA to
assess AS severity. However, the use of MDCT is not
mandatory in clinical routine for evaluation of AS
severity, and echocardiography should remain the
ﬁrst-line of evaluation. Nevertheless, MDCT may
be helpful in patients in whom there is a doubt
about the aortic annulus diameter measurements by
echocardiography for any reasons.
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APPENDIX For an expanded Methods section
as well as supplemental tables and ﬁgures,
please see the online version of this article.
